ABSTRACT
Metastatic malignant cells in bone may induce changes there in a variety of ways:
(a) By direct invasion of the bone marrow with lysis of bone elements by the combined effects of osteolysis, "pressure", ischaemia or hyperaemia (Shivas et al. 1963; Gorenham 8c Test 1964) . The effects are similar to those of fracturepain, oedema and deformity and at the microscopic level, a mixture of in¬ flammatory and reparatory changes (Galasko 1972 ).
(b) By the hormonal stimulation of the normal bone cells to increase the rate of bone destruction. The clinical presentation is one of bone pain, although fracture may be a late presenting feature. Histologically, the picture is similar to that of hyperparathyroidism: an increase in osteoclastic activity, multiple résorption cavities not lined by malignant cells and an excess of woven bone (Galasko 1972) . Increased levels of immunocreative parathyroid hormone have been found in patients in this group (Tashjian et al. 1964; Sherwood et al. 1967) . Studies of the urinary excretion of calcium in patients with carcinoma of the breast when compared with the plasma calcium concentration, suggested increased tubular résorption of calcium, a finding typical of hyperparathyroid¬ ism (Nordin 8c Peacock 1969) . Studies with 4;Ca in these patients suggested an overall increase in bone turnover in keeping with a diffuse hormonal change (Parsons et al. 1970 (Anderson et al. 1967 ). Scans were carried out using 85Sr or 8"mSr (Parsons et al. 1968 The two hypercalcaemic patients showed striking falls from 12.5 mg/100 ml to 9.8 ml/100 ml (MC) and from 15.1 to 9.5 mg/100 ml (KR (Fig. 9) Bordier et al. 1969) .
The rises and falls in total urinary hydroxyproline are more difficult to interpret as some of the excreted peptides are the result of the synthesis as well as the destruction of collagen as seen in studies of Paget's disease using labelled proline (Krane et al. 1970) or in the healing of rat rickets (Parsons et al. 1973 ).
On this basis, a fall in excretion of THP can represent a decrease in bone breakdown and a rise as part of the healing tumour induced osteomalacia.
The hypercalcaemic patients showed changes in the serum alkaline phos¬ phatase, reminiscent of the increases seen in patients who have had parathyroid tumours removed (Smith 1969) .
Calcitonin action seemed on several occasions to be enhanced by the simul¬ taneous administration of phosphate, the latter being relatively ineffective on its own save in its known action in hypercalcaemic patients (Goldsmith 8c Ingbar 1966) . This mechanism probably acts at a cellular level at the bone cell surface rather than by simply raising the serum phosphate concentration of Cax P04 product, as in one patient (JB) the phosphate concentration fell during the period of maximum effect and was maintained around 3 mg/100 ml in MC. Nichols (1970) 
